Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/13433

3,3'-Dimethoxybenzidine-4,4'-diisocyanate: Target Organs and Levels of Evidence for TR-128

Bioassay of 3,3'-Dimethoxybenzidine-4,4'-diisocyanate for Possible Carcinogenicity (CASRN 91-93-0)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
3,3'-Dimethoxybenzidine-4,4'-diisocyanate
91-93-0
08/31/1978Dosed-Feed
0,22000,44000 PPM/50 PER GROUP
Litton Bionetics, Inc.

Levels of Evidence

Male Rats: Positive
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Skin: (BASAL CELL ADENOMA, SQUAMOUS CELL CARCINOMA)
  • Hematopoietic System: (LYMPHOMA OR LEUKEMIA)
  • Zymbal Gland: (CARCINOMA)
Female Rats: Positive
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Hematopoietic System: (LYMPHOMA OR LEUKEMIA)
  • Uterus/Cervix: (POLYP)
  • Zymbal Gland: (CARCINOMA)
Male Mice: Negative
Female Mice: Negative